Double Chin Treatment Belkyra

DOUBLE CHIN TREATMENT BELKYRA

A NON-SURGICAL TREATMENT FOR EXCESSIVE FAT UNDER THE CHIN


. . .


Very few people like having excess fat under their chin and often, despite dieting and exercise it can be difficult to get rid of. Belkyra offers a non surgical option using injections only. 

WHAT IS BELKYRA?


Belkyra is a synthetic Deoxycholic acid which is normally found in the gall bladder. When injected under the chin it breaks down fat cells which are then removed by the body. 


HOW MANY TREATMENTS ARE REQUIRED?


It takes time to dissolve fat, so treatments are spaced 2 months apart. On average most people see a difference within 2 to 4 treatments. 


WHAT ARE LIKELY SIDE EFFECTS?


These can include bruising, redness and numbness. Swelling under the chin can persist for several weeks post treatment.

PRICES

BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Do not use in people allergic to this medicine, with infection at site of injection, pregnancy and lactation. Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/pain/swelling/numbness/redness/tingling/hardness/itching/discolouration/formation of small areas of hardness/warmth and injection site nerve injury. BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at https://www.medsafe.govt.nz/ or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to four years.


BELKYRA® and its design are trademarks of Kythera Biopharmaceuticals, Inc., an Allergan affiliate. ™Trademark of Allergan, Inc. Allergan Australia Pty Ltd, 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan. All rights reserved.


Share by: